New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseases-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New steps in infliximab therapeutic drug monitoring in patients with inflammatory bowel diseases

Published:2019-01-28 Issue:4 Volume:85 Page:722-728
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Nemoz Benjamin¹,Ternant David²,Bailly Sébastien³⁴,Gautier‐Veyret Elodie¹³⁵,Jourdil Jean‐François¹,Bonaz Bruno⁶,Stanke‐Labesque Françoise¹³⁵^ORCID

Affiliation:

1. Laboratory of Pharmacology, Toxicology and PharmacogeneticsGrenoble‐Alpes University Hospital Grenoble France

2. Laboratory of Pharmacology‐ToxicologyCHRU de Tours University Hospital France

3. INSERM U1042, HP2 Grenoble France

4. EFCR Laboratory, Pole Thorax et VaisseauxGrenoble Alpes University Hospital Grenoble France

5. Univ. Grenoble Alpes Grenoble France

6. Division of Hepato‐GastroenterologyUniversity Hospital Grenoble‐Alpes France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.13845

Reference24 articles.

1. The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY

2. Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease

3. Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease

4. Comparison of Three Assays to Quantify Infliximab, Adalimumab, and Etanercept Serum Concentrations

5. Therapeutic drug monitoring of infliximab: performance evaluation of three commercial ELISA kits

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Monitorización terapéutica de los fármacos biológicos en la enfermedad inflamatoria intestinal. Documento de Posicionamiento del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU);Gastroenterología y Hepatología;2024-05

2. Therapeutic drug monitoring in inflammatory bowel diseases. Position statement of the Spanish Working Group on Crohn’s Disease and Ulcerative Colitis;Gastroenterología y Hepatología (English Edition);2024-05

3. Evaluation of Proactive Therapeutic Drug Monitoring Application in Infliximab Users in Ulcerative Colitis;Journal of Coloproctology;2023-11-27

4. Quantification of infliximab and adalimumab in human plasma by a liquid chromatography tandem mass spectrometry kit and comparison with two ELISA methods;Bioanalysis;2022-06

5. Personalized Medicine of Monoclonal Antibodies in Inflammatory Bowel Disease: Pharmacogenetics, Therapeutic Drug Monitoring, and Beyond;Frontiers in Pharmacology;2021-02-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3